- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02298790
Effect of Dietary Habits on Metabolic Health
November 2, 2020 updated by: Frank AJL Scheer, PhD, Brigham and Women's Hospital
The goal of this application is to understand the connection between people's eating habits and the risk for developing diabetes, obesity, and cardiovascular disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
More than a third of U.S. adults are obese (BMI greater than 30), 8-12% of adults suffer from type 2 diabetes, and up to 30% of adults have pre-diabetes.
Recent research studies have suggested that it is not just what we eat, but also when we eat that may put us at risk for obesity and type 2 diabetes.
Skipping breakfast and eating late at night have been associated with an increased risk for obesity and type 2 diabetes (T2D), substantiated by recent animal and human experimental studies showing that altered meal timing itself, without changes in caloric intake, can influence weight regulation and impaired glucose tolerance.
This research will determine in prediabetic and non-diabetic participants whether delaying meal times worsens glucose tolerance, leads to physiological changes favoring a positive energy balance, and increases caloric intake.
This research will provide mechanistic insights into the metabolic consequences of changing meal timing and may help in evidence-based approaches to improve dietary interventions in the fight against obesity and T2D.
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI between 25 and 37.9 kgm-2
- Adults with regular sleep-wake timing
- Non-smokers
- Completion of medical and psychological screening tests
- Able to spend 14 consecutive days in the sleep laboratory
Exclusion Criteria:
- BMI < 25 or > 37.9 kgm-2
- History of neurological or psychiatric disorder
- History of sleep disorder or regular use of sleep-promoting medication
- Current prescription, herbal, or over-the-counter medication use
- Traveling across 2 or more time zones within past 3 months
- Donating blood within past 8 weeks
- Worked night or rotating shift work within past 3 years
- Hearing impairment
- Drug or alcohol dependency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Early Meals
Meals are eaten early in the wake episode
|
|
Experimental: Late Meals
Meals are eaten late in the wake episode
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in plasma leptin levels across sleep/wake cycle
Time Frame: During standardized meals scheduled on Days 3 and 6
|
Frequent blood samples
|
During standardized meals scheduled on Days 3 and 6
|
Change in circadian profile of plasma leptin
Time Frame: During constant routine (Days 7-8)
|
Frequent blood samples
|
During constant routine (Days 7-8)
|
Change in glucose tolerance
Time Frame: During standardized meals scheduled on Days 3 and 6
|
Frequent blood samples
|
During standardized meals scheduled on Days 3 and 6
|
Change in circadian profile of plasma glucose levels
Time Frame: During constant routine (Days 7-8)
|
Frequent blood samples
|
During constant routine (Days 7-8)
|
Change in plasma insulin levels after standardized test meal
Time Frame: During standardized meals scheduled on Days 3 and 6
|
Frequent blood samples
|
During standardized meals scheduled on Days 3 and 6
|
Change in circadian profile of plasma insulin levels
Time Frame: During constant routine (Days 7-8)
|
Frequent blood samples
|
During constant routine (Days 7-8)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in circadian phase markers, such as from core body temperature, melatonin, cortisol
Time Frame: During constant routine (Days 7-8)
|
Core temperature and frequent blood samples
|
During constant routine (Days 7-8)
|
Changes circadian rhythm in resting energy expenditure
Time Frame: During constant routine (Days 7-8)
|
Indirect calorimetry
|
During constant routine (Days 7-8)
|
Change in hunger and appetite, mood, and cognitive performance
Time Frame: Tests taken throughout the protocol, Days 1-9
|
Subjective ratings and cognitive tests performed via computer interface
|
Tests taken throughout the protocol, Days 1-9
|
Changes in microbiota, gene expression, epigenetic or proteomic markers
Time Frame: Throughout the protocol during Days 3 and 6, and during constant routine (Days 7-8)
|
Frequent blood samples and saliva samples
|
Throughout the protocol during Days 3 and 6, and during constant routine (Days 7-8)
|
Changes in sleep
Time Frame: Sleep will be measured during the night after Days 2 and 5
|
Polysomnography
|
Sleep will be measured during the night after Days 2 and 5
|
Change in insulin sensitivity, gene expression, epigenetic, lipidomic or proteomic markers from isolated adipocytes
Time Frame: On Day 5 of each protocol
|
2 fat biopsies, one sample will be taken during each protocol
|
On Day 5 of each protocol
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Frank AJL Scheer, PhD, Brigham and Women's Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
April 21, 2019
Study Completion (Actual)
April 21, 2019
Study Registration Dates
First Submitted
November 20, 2014
First Submitted That Met QC Criteria
November 20, 2014
First Posted (Estimate)
November 24, 2014
Study Record Updates
Last Update Posted (Actual)
November 4, 2020
Last Update Submitted That Met QC Criteria
November 2, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01DK099512 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
Clinical Trials on Meal schedule
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedCircadian DysregulationUnited States
-
Lexicon PharmaceuticalsCompleted
-
University of OxfordCompleted
-
China Medical University HospitalCompleted
-
Ontario Clinical Oncology Group (OCOG)Canadian Breast Cancer Research AllianceCompleted
-
Essentia HealthMinnesota Cancer Clinical Trials NetworkRecruitingMaintenance of Implanted Port DevicesUnited States
-
Rutgers, The State University of New JerseyRecruitingIncreasing Functional Communicative Behavior | Decreasing Destructive BehaviorUnited States
-
Ontario Clinical Oncology Group (OCOG)Completed
-
Maria Sklodowska-Curie National Research Institute...National Center for Research and Development, PolandCompleted
-
National Taiwan University HospitalCompleted